Reflections on the recently published Lancet Series on the role of the private sector in achieving UHC
Who has access to quality health information through electronic platforms (eHealth)?
Influential global health actors are working to narrow the pharmaceutical gap between high- and low-income countries
Geospatial analysis revealed an inherent logic in the coverage of facilities responsive to market niche
Antibiotic or antimicrobial resistance is increasingly recognised as one of the major health challenges of our time
How will countries deliver on this agenda, and what role can and should the private sector play?